Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland
· Delayed Price · Currency is CHF 52.80
+0.80 (1.54%)
At close: Mar 9, 2026
Basilea Pharmaceutica AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 649 | 672 | 501 | 423 | 546 | 485 | Upgrade
|
| Market Cap Growth | 20.91% | 34.10% | 18.52% | -22.52% | 12.62% | -15.59% | Upgrade
|
| Enterprise Value | 578 | 641 | 551 | 505 | 636 | 551 | Upgrade
|
| Last Close Price | 52.80 | 54.70 | 41.35 | 35.30 | 45.80 | 40.92 | Upgrade
|
| PE Ratio | 16.80 | 16.70 | 6.46 | 40.47 | 44.94 | - | Upgrade
|
| Forward PE | 13.60 | 13.26 | 10.63 | 15.17 | 98.35 | - | Upgrade
|
| PS Ratio | 2.79 | 2.89 | 2.40 | 2.68 | 3.69 | 3.27 | Upgrade
|
| PB Ratio | 5.07 | 5.25 | 6.19 | -42.28 | -26.35 | -8.27 | Upgrade
|
| P/TBV Ratio | 5.09 | 5.27 | 6.22 | - | - | - | Upgrade
|
| P/FCF Ratio | 10.91 | 11.30 | 6.90 | 31.48 | 139.32 | - | Upgrade
|
| P/OCF Ratio | 10.45 | 10.83 | 6.74 | 29.69 | 77.36 | - | Upgrade
|
| EV/Sales Ratio | 2.49 | 2.76 | 2.64 | 3.20 | 4.31 | 3.72 | Upgrade
|
| EV/EBITDA Ratio | 10.28 | 11.85 | 8.68 | 21.78 | 29.31 | 154.82 | Upgrade
|
| EV/EBIT Ratio | 11.07 | 12.26 | 8.93 | 23.05 | 30.58 | 183.33 | Upgrade
|
| EV/FCF Ratio | 9.73 | 10.77 | 7.58 | 37.59 | 162.43 | - | Upgrade
|
| Debt / Equity Ratio | 0.70 | 0.70 | 1.38 | -12.86 | -9.03 | -3.74 | Upgrade
|
| Debt / EBITDA Ratio | 1.59 | 1.59 | 1.71 | 5.05 | 7.76 | 41.61 | Upgrade
|
| Debt / FCF Ratio | 1.50 | 1.50 | 1.54 | 9.57 | 47.76 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.55 | -0.55 | -0.11 | -6.86 | -4.95 | -1.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.30 | -1.30 | -0.14 | 2.96 | 4.72 | 19.72 | Upgrade
|
| Net Debt / FCF Ratio | -1.19 | -1.19 | -0.12 | 5.11 | 26.16 | -2.15 | Upgrade
|
| Asset Turnover | 0.86 | 0.86 | 0.97 | 0.80 | 0.63 | 0.62 | Upgrade
|
| Inventory Turnover | 5.46 | 5.46 | 3.99 | 4.13 | 4.18 | 5.33 | Upgrade
|
| Quick Ratio | 4.53 | 4.53 | 3.93 | 2.48 | 1.96 | 1.22 | Upgrade
|
| Current Ratio | 5.12 | 5.12 | 4.85 | 3.20 | 2.34 | 1.38 | Upgrade
|
| Return on Equity (ROE) | 38.52% | 38.52% | 218.58% | - | - | - | Upgrade
|
| Return on Assets (ROA) | 12.10% | 12.10% | 17.89% | 6.95% | 5.56% | 0.79% | Upgrade
|
| Return on Invested Capital (ROIC) | 79.90% | 70.88% | 94.46% | 31.17% | 44.56% | - | Upgrade
|
| Return on Capital Employed (ROCE) | 22.40% | 22.40% | 29.10% | 17.40% | 14.30% | 4.10% | Upgrade
|
| Earnings Yield | 6.20% | 5.99% | 15.48% | 2.47% | 2.23% | -1.41% | Upgrade
|
| FCF Yield | 9.16% | 8.85% | 14.50% | 3.18% | 0.72% | -6.73% | Upgrade
|
| Buyback Yield / Dilution | 1.23% | 1.23% | -14.10% | -1.67% | -2.24% | -13.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.